SCHEMBL158233

SCHEMBL158233

CCCCCC(CC)(CC)OC(=O)CCCCC(=O)OC(CC)(CC)CCCCC

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.47
LMNA P02545 3/20 0.44
PAM P19021 2/20 0.43
MAPT P10636 2/20 0.42
MAPK1 P28482 1/20 0.42
CES2 O00748 4/20 0.41
CES1 P23141 4/20 0.41
TSHR P16473 2/20 0.41
AKR1B1 P15121 1/20 0.40
ALDH1A1 P00352 2/20 0.40
DNM1 Q05193 1/20 0.40
NAAA Q02083 1/20 0.40
FAAH O00519 1/20 0.39
SLC22A6 Q4U2R8 1/20 0.39
SLC22A8 Q8TCC7 1/20 0.39
GPR84 Q9NQS5 1/20 0.39
PPARG P37231 1/20 0.39
PPARD Q03181 1/20 0.39
PPARA Q07869 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28036055 0.98 DGKA (0.50) DGKALMNAPAMMAPTMAPK1
SCHEMBL6397465 0.98 DGKA (0.50) DGKALMNAPAMMAPTMAPK1
SCHEMBL182513 0.98 DGKA (0.50) DGKALMNAPAMMAPTMAPK1
SCHEMBL5701162 0.98 DGKA (0.50) DGKALMNAPAMMAPTMAPK1
SCHEMBL19471288 0.98 DGKA (0.50) DGKALMNAPAMMAPTMAPK1
SCHEMBL10527741 0.96 DGKA (0.48) DGKALMNAPAMMAPTMAPK1
SCHEMBL5864687 0.96 DGKA (0.42) DGKALMNAPAMMAPTMAPK1
SCHEMBL19583405 0.94 DGKA (0.50) DGKALMNAPAMMAPTMAPK1
SCHEMBL18204385 0.94 DGKA (0.50) DGKALMNAPAMMAPTMAPK1
SCHEMBL129475 0.94 DGKA (0.39) DGKALMNAPAMCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1423 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2026085578-A1 RESIDUAL INSECTICIDE COMPOSITION AND USE THEREOF CALLINGTON HAVEN PTY LTD (AU) 2026-04-30 WO claimed
WO-2026085577-A1 INSECTICIDE COMPOSITION AND USE THEREOF CALLINGTON HAVEN PTY LTD (AU) 2026-04-30 WO claimed
EP-4688725-A1 FATTY ACID ESTERS OF HYDROXY FATTY ACID Wilmar International Limited (SG) 2026-02-11 EP claimed
US-20250269034-A1 TOPICAL TETRACYCLINE COMPOSITIONS JOURNEY MEDICAL CORP (US) 2025-08-28 US claimed
WO-2025090562-A1 FORMULATIONS OF ALK-5 KINASE INHIBITORS AND USES THEREOF THIRONA BIO, INC. (US) 2025-05-01 WO claimed
US-20250134875-A1 FORMULATIONS OF ALK-5 KINASE INHIBITORS AND USES THEREOF THIRONA BIO, INC. (US) 2025-05-01 US claimed
US-20250127702-A1 SUNSCREEN COMPOSITION WITH CRYSTALLINE ORGANIC SUNSCREEN FILTERS EDGEWELL PERSONAL CARE BRANDS, LLC 2025-04-24 US claimed
CN-119446702-A To-be-cut piece of laminated inductor, preparation method of to-be-cut piece and single sintered body 潮州三环(集团)股份有限公司 2025-02-14 CN claimed
CN-119015394-A Sulfur-containing compound preparation, and preparation method and application thereof 上海优斐斯生物科技有限公司 2024-11-26 CN claimed
US-12138311-B2 Topical tetracycline compositions JOURNEY MEDICAL CORPORATION (US) 2024-11-12 US claimed
WO-2003078556-A1 LUBRICANT FOR TWO-CYCLE ENGINES NCH CORPORATION (US) 2003-09-25 WO claimed
US-20030176301-A1 Lubricant for two-cycle engines NCH CORPORATION 2003-09-18 US claimed
US-6431219-B1 Coextruded tubing ALARIS MEDICAL SYSTEMS, INC. 2002-08-13 US claimed
US-20020104574-A1 COEXTRUDED TUBING CAREFUSION 303, INC. 2002-08-08 US claimed
EP-0799418-B1 A CARBON DIOXIDE SENSITIVE MATERIAL SEALED AIR NZ LTD (NZ) 1999-05-26 EP claimed
US-5849594-A Carbon dioxide sensitive material SEALED AIR (NZ) LIMITED (NZ) 1998-12-15 US claimed
EP-0799418-A1 A CARBON DIOXIDE SENSITIVE MATERIAL Sealed Air (NZ) Limited (NZ) 1997-10-08 EP claimed
WO-1996019727-A1 A CARBON DIOXIDE SENSITIVE MATERIAL SEALED AIR (NZ) LIMITED (NZ) 1996-06-27 WO claimed
EP-0683390-A1 Current detection type ion selective electrode KYOTO DAIICHI KAGAKU CO., LTD. (JP) 1995-11-22 EP claimed
US-4774275-A PHOSPHITE HEAT STABILIZERS, DIPHENYL ETHER TOKUYAMA SODA KABUSHIKI KAISHA (JP) 1988-09-27 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250134875-A1 FORMULATIONS OF ALK-5 KINASE INHIBITORS AND USES THEREOF ALK, ACVR1, ACVRL1 DGKA 329/4885LMNA 966/4885PAM 4330/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.